<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(3)</volume><submitter>Agarwal R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Leptin, a 16 kDa peptide hormone synthesized and secreted specifically from white adipose cells protects neurons against amyloid β-induced toxicity, by increasing Apolipoprotein E (APO E)-dependent uptake of β amyloid into the cells, thereby, protect individuals from developing Alzheimer's disease (AD). The APO E ε4 allele is a known genetic risk factor for AD by accelerating onset. It is estimated that the lifetime risk of developing AD increases to 29% for carriers with one ε4 allele and 9% for those with no ε4 allele.&lt;h4>Objectives&lt;/h4>To determine the levels of serum leptin, cholesterol, low density lipoprotein (LDL-C), and high density lipoprotein (HDL-C) in the diagnosed cases of AD and the association of them with cognitive decline and Apolipoprotein E (APO E) gen</pubmed_abstract><journal>Annals of Indian Academy of Neurology</journal><pagination>320-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4564468</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.</pubmed_title><pmcid>PMC4564468</pmcid><pubmed_authors>Kushwaha SS</pubmed_authors><pubmed_authors>Agarwal R</pubmed_authors><pubmed_authors>Kukreti R</pubmed_authors><pubmed_authors>Tripathi CB</pubmed_authors><pubmed_authors>Talwar P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease.</name><description>&lt;h4>Background&lt;/h4>Leptin, a 16 kDa peptide hormone synthesized and secreted specifically from white adipose cells protects neurons against amyloid β-induced toxicity, by increasing Apolipoprotein E (APO E)-dependent uptake of β amyloid into the cells, thereby, protect individuals from developing Alzheimer's disease (AD). The APO E ε4 allele is a known genetic risk factor for AD by accelerating onset. It is estimated that the lifetime risk of developing AD increases to 29% for carriers with one ε4 allele and 9% for those with no ε4 allele.&lt;h4>Objectives&lt;/h4>To determine the levels of serum leptin, cholesterol, low density lipoprotein (LDL-C), and high density lipoprotein (HDL-C) in the diagnosed cases of AD and the association of them with cognitive decline and Apolipoprotein E (APO E) gen</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jul-Sep</publication><modification>2025-04-18T17:02:33.63Z</modification><creation>2019-03-27T01:58:06Z</creation></dates><accession>S-EPMC4564468</accession><cross_references><pubmed>26425011</pubmed><doi>10.4103/0972-2327.157255</doi></cross_references></HashMap>